CHRONIC HEART FAILURE: MODERN DIAGNOSTIC AND THERAPEUTIC APPROACHES

Fuente: Zenodo
Saved in:
Bibliographic Details
Main Authors: Salohiddinova Hojaroy, Toshqinpo'latova Dilshoda, Sobirov Olimjon Odiljonovich
Format: Recurso digital
Published: Zenodo 2025
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866902093535641600
author Salohiddinova Hojaroy
Toshqinpo'latova Dilshoda
Sobirov Olimjon Odiljonovich
author_facet Salohiddinova Hojaroy
Toshqinpo'latova Dilshoda
Sobirov Olimjon Odiljonovich
contents <p><span lang="EN-US">Chronic heart failure (CHF) is a complex clinical syndrome characterized by the heart's persistent inability to pump blood adequately to meet the body's demands or to receive blood effectively. This article provides a comprehensive scientific overview of CHF's pathophysiology, modern diagnostic methods, and treatment strategies. The pathogenesis of CHF involves myocardial systolic or diastolic dysfunction, neurohormonal activation, inflammatory processes, and oxidative stress. Diagnostic approaches emphasize the role of echocardiography, natriuretic peptides (BNP, NT-proBNP), and cardiac magnetic resonance imaging (MRI) in accurate assessment. Treatment strategies include pharmacological interventions such as angiotensin receptor-neprilysin inhibitors (ARNI), sodium-glucose cotransporter-2 inhibitors (SGLT2i), beta-blockers, and mineralocorticoid receptor antagonists, alongside device-based therapies like implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy (CRT). Lifestyle modifications and cardiac rehabilitation are integral to improving patients' functional status. Emerging research on gene and cell therapies, as well as artificial intelligence-based models, offers promising future directions. The article underscores the importance of early diagnosis and individualized treatment to enhance patient outcomes and quality of life.</span></p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_15817214
institution Zenodo
language
publishDate 2025
publisher Zenodo
record_format zenodo
spellingShingle CHRONIC HEART FAILURE: MODERN DIAGNOSTIC AND THERAPEUTIC APPROACHES
Salohiddinova Hojaroy
Toshqinpo'latova Dilshoda
Sobirov Olimjon Odiljonovich
Chronic heart failure, pathophysiology, echocardiography, natriuretic peptides, ARNI, SGLT2 inhibitors, beta-blockers, implantable cardioverter-defibrillator, cardiac resynchronization therapy, gene therapy, cell therapy, cardiac rehabilitation.
<p><span lang="EN-US">Chronic heart failure (CHF) is a complex clinical syndrome characterized by the heart's persistent inability to pump blood adequately to meet the body's demands or to receive blood effectively. This article provides a comprehensive scientific overview of CHF's pathophysiology, modern diagnostic methods, and treatment strategies. The pathogenesis of CHF involves myocardial systolic or diastolic dysfunction, neurohormonal activation, inflammatory processes, and oxidative stress. Diagnostic approaches emphasize the role of echocardiography, natriuretic peptides (BNP, NT-proBNP), and cardiac magnetic resonance imaging (MRI) in accurate assessment. Treatment strategies include pharmacological interventions such as angiotensin receptor-neprilysin inhibitors (ARNI), sodium-glucose cotransporter-2 inhibitors (SGLT2i), beta-blockers, and mineralocorticoid receptor antagonists, alongside device-based therapies like implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy (CRT). Lifestyle modifications and cardiac rehabilitation are integral to improving patients' functional status. Emerging research on gene and cell therapies, as well as artificial intelligence-based models, offers promising future directions. The article underscores the importance of early diagnosis and individualized treatment to enhance patient outcomes and quality of life.</span></p>
title CHRONIC HEART FAILURE: MODERN DIAGNOSTIC AND THERAPEUTIC APPROACHES
topic Chronic heart failure, pathophysiology, echocardiography, natriuretic peptides, ARNI, SGLT2 inhibitors, beta-blockers, implantable cardioverter-defibrillator, cardiac resynchronization therapy, gene therapy, cell therapy, cardiac rehabilitation.
url https://doi.org/10.5281/zenodo.15817214